Concepedia

Özlem Göker-Alpan

ÖG

Statistics

Publications

71

Citations

5K

H-Index

35

Active since

2002

Affiliations

Lysosomal and Rare Disorders Research and Treatment Center(Current)

O&O Alpan (United States)

National Human Genome Research Institute

National Institutes of Health

Duke Medical Center

Özlem Göker-Alpan is an author at Lysosomal and Rare Disorders Research and Treatment Center specializing in medicine, pathology, and neuropathology.

Top concepts

MedicinePathologyNeuropathologyNeurologyGeneticsLysosomal Storage DiseaseSubstrate Reduction TherapyHematologyAutoimmune DiseaseNeurodegenerative Diseases

Publications per year

2002–2024

71

Publications

71

Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat

Dominique P. Germain, Derralynn Hughes, Daniel G. Bichet et al. · New England Journal of Medicine · 2016 · 535 citations · Full text

Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study

Derralynn Hughes, Suma P. Shankar, Gere Sunder‐Plassmann et al. · Journal of Medical Genetics · 2016 · 370 citations · Full text

Parkinsonism among Gaucher disease carriers

Özlem Göker-Alpan · Journal of Medical Genetics · 2004 · 363 citations · Full text

Neurodegenerative Diseases, Mendelian Disorder, Gaucher Disease +12

Glucocerebrosidase mutations are an important risk factor for Lewy body disorders

Özlem Göker-Alpan, Benoit I. Giasson, Michael J. Eblan et al. · Neurology · 2006 · 227 citations

Lysosomal Protein, Important Risk Factor, Genetics +22

The Spectrum of Parkinsonian Manifestations Associated With Glucocerebrosidase Mutations

Özlem Göker-Alpan, Grisel Lopez, Joseph Vithayathil et al. · Archives of Neurology · 2008 · 195 citations · Full text

1–5 of 71